査読有
doi：10.3350/cmh.2025.0983
PubMed No.：40994082
2024 Impact Factor：16.9
種類：Research Letter
誌名：Clinical and Molecular Hepatology
発行年月：2025年9月
巻号頁：in press
論題：Distinct TIME Modulation by Anti-PD-1/PD-L1, VEGF, and CTLA-4 Blockade Provides a Rationale for Triplet Therapy in HCC
著者：Hideki Iwamoto, Hironori Koga, Takumi Kawaguchi
